Regulation of VEGF-activated signalling by the plasma membrane calcium ATPase 4 in endothelial cells
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsImmanuel, Reshma Naomi Ranjit
MetadataShow full item record
AbstractINTRODUCTION: Angiogenesis, the formation of new blood vessels from pre-existing ones. It is a tightly regulated processes involving pro- and anti-angiogenic molecules. Deregulation of this process is associated with aberrant blood vessel formation (excessive or insufficient) in several human pathologies. Among the many pro-angiogenic factors promoting angiogenesis, the vascular endothelial growth factor (VEGF) has been characterised as a major regulator of both physiological and pathological angiogenesis. Therefore, the characterisation of the molecular mechanisms that regulate VEGF-induced angiogenesis is essential to develop therapeutic strategies that correct abnormal angiogenesis. In this sense, our group has previously reported a negative role for the Plasma Membrane Calcium ATPase 4 (PMCA4) protein in endothelial cells, acting via inhibition of the pro-angiogenic calcineurin/NFAT signalling pathway. However, we hypothesise that other intracellular pathways might be regulated by PMCA4 in endothelial cells during VEGF stimulation of angiogenesis. METHODS: To identify PMCA4 regulated pro-angiogenic signalling pathways, we have screened gene arrays related to Notch signalling or extracellular matrix-Cell Adhesion Molecule (ECM-CAM) pathway using RNA isolated from PMCA4-silenced (or control) HUVEC. Changes in gene expression after PMCA4 knockdown have been further validated by TaqMan-based qPCR in HUVEC or HDMEC. RNA levels of PMCA4 in aging HUVEC were analysed by TaqMan qPCR using RNA isolated from HUVEC cultured from different passages (from 3 to 15 passages). RESULTS: siRNA-mediated PMCA4 knockdown led to increased expression of Notch ligand DLL1 and Notch target gene Hey1 in VEGF-stimulated HUVEC. Expression of the transcription factor c-Fos was also elevated after PMCA4 knockdown in HUVEC stimulated with VEGF for 1h. Analysis of a gene array containing genes encoding extracellular matrix and cell adhesion molecules revealed that PMCA4 silencing alters the basal expression of P-Selectin and L-Selectin in HUVEC. The expression of other genes in the array like, ADAMTS-1, E-Selectin, and VCAM-1, was affected by lack of PMCA4, but only when cells were stimulated with VEGF. Examination of changes in the expression of these genes in PMCA4-silenced HUVEC or HDMEC showed differences indicating that PMCA4 might differentially regulate these genes in different sub-types of endothelial cells. In conclusion, our results suggest that PMCA4 negatively regulates Notch signaling pathway, and it is required for proper synthesis of ECM-CAM molecules. A first step to investigate the expression of PMCA4 in endothelial cells during aging has shown that PMCA4 mRNA levels increase along cell culture passage in HUVEC. However, this initial result requires further verification of changes in PMCA4 protein levels and/or in other cellular types to conclude that PMCA4 expression increases with aging.
PublisherUniversity of Wolverhampton
TypeThesis or dissertation
DescriptionA thesis submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Master of Philosophy.
The following licence applies to the copyright and re-use of this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Showing items related by title, author, creator and subject.
Transcriptome analysis of gene expression provides new insights into the effect of mild therapeutic hypothermia on primary human cortical astrocytes cultured under hypoxiaSalman, Mootaz M; Kitchen, Philip; Woodroofe, M Nicola; Bill, Roslyn M; Conner, Alex C; Heath, Paul R; Conner, Matthew T. (Frontiers Media, 2017-12-14)Hypothermia is increasingly used as a therapeutic measure to treat brain injury. However, the cellular mechanisms underpinning its actions are complex and are not yet fully elucidated. Astrocytes are the most abundant cell type in the brain and are likely to play a critical role. In this study, transcriptional changes and the protein expression profile of human primary cortical astrocytes cultured under hypoxic conditions for 6 h were investigated. Cells were treated either with or without a mild hypothermic intervention 2 h post-insult to mimic the treatment of patients following traumatic brain injury (TBI) and/or stroke. Using human gene expression microarrays, 411 differentially expressed genes were identified following hypothermic treatment of astrocytes following a 2 h hypoxic insult. KEGG pathway analysis indicated that these genes were mainly enriched in the Wnt and p53 signaling pathways, which were inhibited following hypothermic intervention. The expression levels of 168 genes involved in Wnt signaling were validated by quantitative real-time-PCR (qPCR). Among these genes, 10 were up-regulated and 32 were down-regulated with the remainder unchanged. Two of the differentially expressed genes (DEGs), p38 and JNK, were selected for validation at the protein level using cell based ELISA. Hypothermic intervention significantly down-regulated total protein levels for the gene products of p38 and JNK. Moreover, hypothermia significantly up-regulated the phosphorylated (activated) forms of JNK protein, while downregulating phosphorylation of p38 protein. Within the p53 signaling pathway, 35 human apoptosis-related proteins closely associated with Wnt signaling were investigated using a Proteome Profiling Array. Hypothermic intervention significantly down-regulated 18 proteins, while upregulating one protein, survivin. Hypothermia is a complex intervention; this study provides the first detailed longitudinal investigation at the transcript and protein expression levels of the molecular effects of therapeutic hypothermic intervention on hypoxic human primary cortical astrocytes. The identified genes and proteins are targets for detailed functional studies, which may help to develop new treatments for brain injury based on an in-depth mechanistic understanding of the astrocytic response to hypoxia and/or hypothermia.
Atmin mediates kidney morphogenesis by modulating Wnt signalingGoggolidou, P.; Hadjirin, N.F.; Bak, A.; Papakrivopoulou, E.; Hilton, H.; Norris, D.P.; Dean, C.H. (Oxford University Press, 2014-05-22)The DNA damage protein and transcription factor Atmin (Asciz) is required for both lung tubulogenesis and ciliogenesis. Like the lungs, kidneys contain a tubular network that is critical for their function and in addition, renal ciliary dysfunction has been implicated in the pathogenesis of cystic kidney disease. Using the Atmin mouse mutant Gasping6 (Gpg6), we investigated kidney development and found it severely disrupted with reduced branching morphogenesis, resulting in fewer epithelial structures being formed. Unexpectedly, transcriptional levels of key cilia associated genes were not altered in Atmin(Gpg6/Gpg6) kidneys. Instead, Gpg6 homozygous kidneys exhibited altered cytoskeletal organization and modulation of Wnt signaling pathway molecules, including β-catenin and non-canonical Wnt/planar cell polarity (PCP) pathway factors, such as Daam2 and Vangl2. Wnt signaling is important for kidney development and perturbation of Wnt signaling pathways can result in cystic, and other, renal abnormalities. In common with other PCP pathway mutants, Atmin(Gpg6/Gpg6) mice displayed a shortened rostral-caudal axis and mis-oriented cell division. Moreover, intercrosses between Atmin(Gpg6/+) and Vangl2(Lp/+) mice revealed a genetic interaction between Atmin and Vangl2. Thus we show for the first time that Atmin is critical for normal kidney development and we present evidence that mechanistically, Atmin modifies Wnt signaling pathways, specifically placing it as a novel effector molecule in the non-canonical Wnt/PCP pathway. The identification of a novel modulator of Wnt signaling has important implications for understanding the pathobiology of renal disease.
The role of WNT signalling in chronic kidney disease (CKD)Malik, SA; Modarage, K; Goggolidou, P; Department of Biomedical Science and Physiology, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UK. (MDPI, 2020-04-30)© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Chronic kidney disease (CKD) encompasses a group of diverse diseases that are associated with accumulating kidney damage and a decline in glomerular filtration rate (GFR). These conditions can be of an acquired or genetic nature and, in many cases, interactions between genetics and the environment also play a role in disease manifestation and severity. In this review, we focus on genetically inherited chronic kidney diseases and dissect the links between canonical and non-canonical Wnt signalling, and this umbrella of conditions that result in kidney damage. Most of the current evidence on the role of Wnt signalling in CKD is gathered from studies in polycystic kidney disease (PKD) and nephronophthisis (NPHP) and reveals the involvement of beta-catenin. Nevertheless, recent findings have also linked planar cell polarity (PCP) signalling to CKD, with further studies being required to fully understand the links and molecular mechanisms.